Zimmer Biomet (ZBH) PT Lowered at Bernstein Amid Organic Growth Miss
Tweet Send to a Friend
Bernstein SocGen Group analyst Lee Hambright lowered the price target on Zimmer Biomet (NYSE: ZBH) to $97.00 (from $105.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
